Department of Ophthalmology, San Raffaele Scientific Institute, Vita-Salute University, Via Olgettina, 60, 20132, Milan, Italy.
Int Ophthalmol. 2023 Aug;43(8):2841-2849. doi: 10.1007/s10792-023-02683-5. Epub 2023 Mar 13.
To identify the characteristics and outcome of panuveitis of undetermined origin (PUO) after diagnostic vitrectomy.
Retrospective analysis of all patients who underwent vitrectomy for diagnostic/therapeutic purposes from 2013 to 2020, whose vitreous biopsies turned out negative and final diagnoses were not clinically supported.
Of 122 operated eyes, 36 eyes (29.5%) were defined as PUO (67.8 ± 14.9 years). The presenting clinical picture revealed a predominantly bilateral condition (70% of eyes) with significant posterior segment involvement: 3.1 ± 0.6 vitritis, 61.1% of eyes with retinal vasculitis, 44.4% with macular edema, and 30.6% with exudative retinal detachment. Presenting visual acuity was 1.2 ± 0.7 logMAR, and up to 90% remained stable or improved vision over a ~ 3.5 year observation period. None of the presenting clinical features turned out to be predictive of final visual outcome or survival.
PUO is present in up to 30% of cases after diagnostic/therapeutic vitrectomy. This mainly bilateral condition shows chronic and overall stable long-term outcome, generally with retained steady visual function.
确定诊断性玻璃体切除术治疗后不明原因全葡萄膜炎(PUO)的特征和结局。
回顾性分析了 2013 年至 2020 年间所有因诊断/治疗目的接受玻璃体切除术的患者,这些患者的玻璃体活检结果为阴性,且最终诊断无法得到临床支持。
122 只手术眼中有 36 只(29.5%)被定义为 PUO(67.8±14.9 岁)。主要表现为双侧疾病(70%的眼睛),后段受累明显:3.1±0.6 级玻璃体炎,61.1%的眼睛出现视网膜血管炎,44.4%出现黄斑水肿,30.6%出现渗出性视网膜脱离。初诊视力为 1.2±0.7 logMAR,在~3.5 年的观察期内,多达 90%的患者视力稳定或改善。初诊时的任何临床特征都不能预测最终的视力结局或生存率。
诊断性/治疗性玻璃体切除术后,多达 30%的患者会出现 PUO。这种主要为双侧疾病的情况表现为慢性和总体稳定的长期结局,通常伴有稳定的视力功能。